Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WALNUT-Diabetes
NCT03334175Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2018
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Number of Participants Recruited and Retained at 12 weeks, Adherence to the Intervention at 12 weeks and 1 more. Started May 2018; status: completed.
Beyond the preview
Go deeper on NCT03334175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334175.